Agreement brings innovative solutions to address emerging disease challenges
RAHWAY, N.J., April 1, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has entered into an agreement with Cambridge Technologies, an independent custom vaccine company based in Worthington, Minn., to sell and market its innovative autogenous poultry vaccines in the United States.
Cambridge Technologies uses cutting-edge molecular diagnostic and manufacturing techniques to develop custom vaccine solutions to help veterinarians and poultry producers manage emerging disease challenges. Through this agreement, Cambridge will contribute its production expertise and distribution while Merck Animal Health will provide its expansive customer reach.
“Merck Animal Health is continuously pursuing innovative ways to deliver value to our customers to improve animal health,” said Jim Tate, executive director, Integrated Livestock business in North America for Merck Animal Health. “For this agreement, we are linking together the reach of our Merck Animal Health sales and marketing teams to offer our customers the diagnostic expertise of Cambridge research scientists to provide flock-specific biologics with customized options.”
Cambridge Technologies vaccines are formulated and produced at its USDA-licensed, 37,000-square-foot manufacturing facility featuring state-of-the-art fermentation suites.
“The Cambridge team has extensive experience in diagnostics, R&D, quality control, technical support, regulatory affairs and commercial and custom vaccine production,” said Jon Mahlberg, chief operating officer for Cambridge Technologies. “Our vaccines are scientifically designed to meet the customer’s specific needs, and we are excited to combine our capabilities with those of Merck Animal Health to meet the unique needs of poultry customers.”
Production of the first vaccine batches is currently being planned. To learn more about these custom vaccine products, contact your Merck Animal Health sales or technical services representative.
About Merck Animal Health
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.
About Cambridge Technologies
Based in Worthington, MN, Cambridge Technologies brings Precision Vaccinology®, our combination of industry-leading diagnostic technology and fully customizable autogenous vaccines, to today’s innovative veterinarians and livestock producers. For more information, visit cambridgetechnologies.com and connect with us on Facebook, Instagram, LinkedIn, and X (formerly Twitter).
Source: Merck Animal Health Press Release